Methamphetamine abuse
Information
- Disease name
- Methamphetamine abuse
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03884946 | Active, not recruiting | N/A | The Getting Off App for Methamphetamine-Using Gay and Bisexual Men | January 30, 2019 | June 15, 2024 |
| NCT04706624 | Active, not recruiting | N/A | Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics | November 2, 2020 | March 31, 2025 |
| NCT04907357 | Active, not recruiting | N/A | rTMS for Stimulant Use Disorders | February 4, 2022 | July 2024 |
| NCT01062451 | Completed | Phase 1 | An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence | May 2009 | November 20, 2013 |
| NCT01063205 | Completed | Phase 1 | NAC as a Potential Treatment for Methamphetamine Dependence | March 2010 | July 2011 |
| NCT01073319 | Completed | Phase 1 | Rivastigmine as a Treatment for Methamphetamine Dependence | July 2009 | July 2010 |
| NCT01365819 | Completed | Phase 2 | Varenicline for Methamphetamine Dependence | February 2012 | August 2014 |
| NCT01571167 | Completed | Phase 1 | Varenicline as a Treatment for Methamphetamine Dependence | January 2011 | February 2012 |
| NCT05550493 | Completed | N/A | Digital Therapeutics Smartphone Application for Methamphetamine Use Disorder | January 1, 2021 | May 1, 2022 |
| NCT00603434 | Completed | Phase 1 | Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH) | January 2008 | March 2009 |
| NCT01011829 | Completed | Phase 2 | Varenicline vs Placebo for the Treatment of Methamphetamine Dependence | November 2009 | May 2010 |
| NCT01603147 | Completed | Phase 1 | Safety Study of Ch-mAb7F9 for Methamphetamine Abuse | April 2012 | July 2013 |
| NCT01822132 | Completed | N/A | Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade | May 2013 | March 2015 |
| NCT01843205 | Completed | Phase 1 | Buspirone as a Candidate Medication for Methamphetamine Abuse | April 2013 | March 2017 |
| NCT01967381 | Completed | Early Phase 1 | Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse | October 2013 | September 2018 |
| NCT02008526 | Completed | N/A | Theory-based Text Messaging to Reduce Methamphetamine Use and HIV Risks Among MSM | January 2014 | January 2017 |
| NCT02907853 | Completed | N/A | Contingency Management for Meth in South Africa Methamphetamine Abuse in South Africa | September 1, 2015 | February 15, 2018 |
| NCT03226223 | Completed | Phase 2 | Pharmacogenetics of Naltrexone for Stimulant Abuse | September 15, 2016 | July 30, 2020 |
| NCT03336866 | Completed | Phase 1/Phase 2 | Study of Antibody for Methamphetamine Outpatient Therapy | May 3, 2018 | March 9, 2021 |
| NCT03709667 | Completed | Early Phase 1 | Exercise in Methamphetamine Use Disorder Upregulation and Neural Function | June 26, 2019 | August 30, 2023 |
| NCT03864653 | Completed | N/A | Depression Intervention Among Gay and Bisexual Men Receiving Treatment for Methamphetamine Use | February 25, 2019 | May 31, 2020 |
| NCT04061941 | Completed | Change in Cognitive Function in Stimulant Users | October 21, 2019 | December 31, 2023 | |
| NCT04109014 | Completed | N/A | FASTLANE II: Reducing Sex, Drug, and Mental Health Risk | May 3, 2021 | December 1, 2021 |
| NCT04264741 | Completed | N/A | Transcranial Magnetic Stimulation for Methadone Maintenance Therapy Combined With Methamphetamine Abuse | February 1, 2020 | December 31, 2022 |
| NCT04544124 | Completed | N/A | Delivering Contingency Management in Outpatient Addiction Treatment | January 25, 2021 | December 8, 2023 |
| NCT05206175 | Completed | N/A | Demonstration of a Digital Care Program for Methamphetamine Use Disorder | February 14, 2022 | December 31, 2022 |
| NCT05266716 | Completed | N/A | Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder | February 18, 2021 | January 7, 2022 |
| NCT00291512 | Completed | Phase 2 | Promoting Safer Sex in HIV+ Homosexual and Bisexual Men Who Use Methamphetamine | ||
| NCT05611385 | Completed | Amphetamine Induced Adult Respiratory Distress Syndrome | January 1, 2019 | January 1, 2020 | |
| NCT05916989 | Completed | Stimulant Use and Methylation in HIV | September 30, 2018 | October 26, 2022 | |
| NCT05334914 | Not yet recruiting | N/A | ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming Individuals | March 1, 2024 | April 1, 2025 |
| NCT06233799 | Not yet recruiting | Phase 3 | Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder | May 1, 2024 | April 30, 2027 |
| NCT06410196 | Not yet recruiting | N/A | Mood and Decision-making in Methamphetamine Use Disorder | July 2024 | July 2026 |
| NCT05784467 | Not yet recruiting | N/A | Methamphetamine, PrEP, and Intersectional Stigma Study | June 1, 2024 | August 31, 2027 |
| NCT05593796 | Not yet recruiting | N/A | Cognitive Behavioral Therapy(CBT) in Treatment of Methamphetamine Use Disorder | September 1, 2023 | March 1, 2025 |
| NCT05971043 | Not yet recruiting | Skin Disease in Methamphetamine Abuse | August 3, 2023 | September 20, 2024 | |
| NCT04616625 | Recruiting | Cardiovascular Effects of Prenatal Methamphetamine Exposure | October 5, 2020 | June 30, 2023 | |
| NCT04927143 | Recruiting | Phase 2 | Encouraging Abstinence Behavior in a Drug Epidemic | September 15, 2021 | December 2024 |
| NCT06292156 | Recruiting | N/A | tACS Treatment for Cognitive Impairments in Methamphetamine Addicts | February 20, 2023 | August 2024 |
| NCT05521854 | Recruiting | N/A | Contingency Management for Drug Use: Does Age Matter? | May 1, 2023 | December 1, 2024 |
| NCT06316973 | Recruiting | Phase 1 | A Clinical Study to Evaluate the Safety of CS-1103 in Healthy Participants | February 7, 2024 | July 2024 |
| NCT03470480 | Recruiting | N/A | rTMS for Craving in Methamphetamine Use Disorder | February 7, 2018 | September 1, 2025 |
| NCT06372288 | Recruiting | N/A | Theta Burst TMS for Treatment of Methamphetamine Use Disorder | December 20, 2023 | December 2025 |
| NCT05700994 | Recruiting | N/A | Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM) | November 13, 2023 | September 30, 2026 |
| NCT05854667 | Recruiting | Phase 2 | Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users | December 5, 2023 | November 2025 |
| NCT04019600 | Suspended | Screening of Pulmonary Hypertension in Methamphetamine Abusers | December 23, 2019 | December 22, 2022 | |
| NCT05034874 | Terminated | Phase 2 | Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 | June 9, 2022 | November 7, 2023 |
| NCT01019707 | Terminated | Phase 1 | Safety Assessment of Atomoxetine With MA IV Administration | October 2009 | December 2010 |
| NCT03059563 | Terminated | Phase 1 | Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users | January 11, 2018 | September 28, 2023 |
| NCT01273701 | Unknown status | N/A | Combination of Psychosocial Intervention and Slow Prosecutions for the Treatment of Methamphetamine Abuse/Dependence | January 2011 | December 2012 |
| NCT00733967 | Withdrawn | Phase 1 | Varenicline-Methamphetamine Interaction Study (2008) | January 2008 | August 2008 |
| NCT04883021 | Withdrawn | N/A | A Pilot Study of Repetitive Transcranial Magnetic Stimulation for Treatment of Methamphetamine Use Disorders | August 1, 2020 | May 31, 2021 |
| NCT01601717 | Withdrawn | Phase 1 | RTI-336 as a Treatment for Methamphetamine Dependence | January 2010 | January 2012 |